UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling

Journal of allergy and clinical immunology, 2015-09, Vol.136 (3), p.667-677.e7

2015

Volltextzugriff (PDF)

Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (Delgocitinib) as a New Dermatological Agent to Treat Inflammatory Skin Disorders

Journal of medicinal chemistry, 2020-07, Vol.63 (13), p.7163-7185

2020

Volltextzugriff (PDF)

Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model

Journal of dermatological science, 2020-02, Vol.97 (2), p.161-164

2020

Volltextzugriff (PDF)

JAK inhibitor JTE-052 regulates contact hypersensitivity by downmodulating T cell activation and differentiation

Journal of dermatological science, 2016-12, Vol.84 (3), p.258-265

2016

Volltextzugriff (PDF)

A novel JAK inhibitor JTE‐052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents

Experimental dermatology, 2018-01, Vol.27 (1), p.22-29

2018

Volltextzugriff (PDF)

Symmetry-based ligand design and evaluation of small molecule inhibitors of programmed cell death-1/programmed death-ligand 1 interaction

Bioorganic & medicinal chemistry letters, 2019-09, Vol.29 (17), p.2464-2467

2019

Volltextzugriff (PDF)

Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo

Inflammation research, 2015-01, Vol.64 (1), p.41-51

2015

Volltextzugriff (PDF)

SAR study of small molecule inhibitors of the programmed cell death‐1/programmed cell death‐ligand 1 interaction

Chemical biology & drug design, 2021-11, Vol.98 (5), p.914-929

2021

Volltextzugriff (PDF)

Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide

Inflammation research, 2012-05, Vol.61 (5), p.445-454

2012

Volltextzugriff (PDF)

Improvement of spontaneous locomotor activity with JAK inhibition by JTE-052 in rat adjuvant-induced arthritis

BMC musculoskeletal disorders, 2015-11, Vol.16 (337), p.339-339, Article 339

2015

Volltextzugriff (PDF)

JAK阻害薬delgocitinibの創製

ファルマシア, 2023, Vol.59(6), pp.536-540

2023

Volltextzugriff (PDF)

JTA–009, a fully human antibody against human AILIM/ICOS, ameliorates graft–vs–host reaction in SCID mice grafted with human PBMCs

Experimental hematology, 2008-11, Vol.36 (11), p.1514-1523

2008

Volltextzugriff (PDF)

Possible participation of intracellular platelet-activating factor in NF-κB activation in rat peritoneal macrophages

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2002-06, Vol.1583 (1), p.26-34

2002

Volltextzugriff (PDF)

Participation of prostaglandin E2 and platelet-activating factor in thapsigargin-induced production of interleukin-6

European journal of pharmacology, 2002-01, Vol.434 (3), p.187-196

2002

Volltextzugriff (PDF)

Possible participation of intracellular platelet-activating factor in tumor necrosis factor-α production by rat peritoneal macrophages

European journal of pharmacology, 1999-06, Vol.374 (3), p.341-350

1999

Volltextzugriff (PDF)

Participation of prostaglandin E 2 and platelet-activating factor in thapsigargin-induced production of interleukin-6

European journal of pharmacology, 2002-01, Vol.434 (3), p.187-196

2002

Volltextzugriff (PDF)

Syringomyelia associated with Hajdu-Cheney syndrome: case report

Neurosurgery, 1996-08, Vol.39 (2), p.400-403

1996

Volltextzugriff (PDF)

Neuropsychological Impairment of the Patients Who Recovered Social Life after Surgery for the Ruptured Anterior Communicating Artery Aneurysm

Surgery for Cerebral Stroke, 2002, Vol.30(4), pp.253-257

2002

Volltextzugriff (PDF)

Inhibition of tumor necrosis factor-α production by SK&F 98625, a CoA-independent transacylase inhibitor, in cultured rat peritoneal macrophages

Life sciences (1973), 1998, Vol.62 (20), p.PL297-PL302

1998

Volltextzugriff (PDF)

A Case of Giant Cell Tumor of Thoracic Vertebrae

Nōshinkei geka jānaru = Japanese journal of neurosurgery, 2003, Vol.12 (10), p.701-706

2003

Volltextzugriff (PDF)

Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages

Biochimica et biophysica acta, 2002-06, Vol.1583 (1), p.26

2002

Volltextzugriff (PDF)

Surgical Strategy for Sylvian Fissure Arteriovenous Malformations

Surgery for Cerebral Stroke, 1993/11/30, Vol.21(6), pp.455-459

1993

Volltextzugriff (PDF)

破裂前交通動脈瘤クリッピング術後長期経過した社会復帰例の高次脳機能の検討

脳卒中の外科, 2002, Vol.30(4), pp.253-257

2002

Volltextzugriff (PDF)

Removal of a Clival Chordoma by Le Fort I Maxillotomy : A Case Report

Nōshinkei geka jānaru = Japanese journal of neurosurgery, 1995, Vol.4 (5), p.478-483

1995

Volltextzugriff (PDF)

Mechanism for the stimulation of platelet-activating factor production by cyclooxygenase inhibitors. Analysis for the participation of prostaglandin E2 and cAMP

Enshō, 1997-09, Vol.17 (5), p.491-497

1997

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(52)

Sprache

Englisch
(45)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling

Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (Delgocitinib) as a New Dermatological Agent to Treat Inflammatory Skin Disorders

Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model

JAK inhibitor JTE-052 regulates contact hypersensitivity by downmodulating T cell activation and differentiation

A novel JAK inhibitor JTE‐052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents

Symmetry-based ligand design and evaluation of small molecule inhibitors of programmed cell death-1/programmed death-ligand 1 interaction

Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo

SAR study of small molecule inhibitors of the programmed cell death‐1/programmed cell death‐ligand 1 interaction

Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide

Improvement of spontaneous locomotor activity with JAK inhibition by JTE-052 in rat adjuvant-induced arthritis

JAK阻害薬delgocitinibの創製

JTA–009, a fully human antibody against human AILIM/ICOS, ameliorates graft–vs–host reaction in SCID mice grafted with human PBMCs

Possible participation of intracellular platelet-activating factor in NF-κB activation in rat peritoneal macrophages

Participation of prostaglandin E2 and platelet-activating factor in thapsigargin-induced production of interleukin-6

Possible participation of intracellular platelet-activating factor in tumor necrosis factor-α production by rat peritoneal macrophages

Participation of prostaglandin E 2 and platelet-activating factor in thapsigargin-induced production of interleukin-6

Syringomyelia associated with Hajdu-Cheney syndrome: case report

Neuropsychological Impairment of the Patients Who Recovered Social Life after Surgery for the Ruptured Anterior Communicating Artery Aneurysm

Inhibition of tumor necrosis factor-α production by SK&F 98625, a CoA-independent transacylase inhibitor, in cultured rat peritoneal macrophages

A Case of Giant Cell Tumor of Thoracic Vertebrae

Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages

Surgical Strategy for Sylvian Fissure Arteriovenous Malformations

破裂前交通動脈瘤クリッピング術後長期経過した社会復帰例の高次脳機能の検討

Removal of a Clival Chordoma by Le Fort I Maxillotomy : A Case Report

Mechanism for the stimulation of platelet-activating factor production by cyclooxygenase inhibitors. Analysis for the participation of prostaglandin E2 and cAMP

Suchergebnisse filtern